Publication:
Klotho gene polymorphism as a susceptibility factor for oxidative DNA damage in coronary artery disease

dc.contributor.authorKARSLI, SEHER
dc.contributor.authorYURDUN, TÜRKAN
dc.contributor.authorsKARSLI S., Yazar S., Karaca M., YURDUN T.
dc.date.accessioned2023-10-03T10:30:47Z
dc.date.accessioned2026-01-10T20:50:16Z
dc.date.available2023-10-03T10:30:47Z
dc.date.issued2023-01-01
dc.description.abstractThe Klotho protein has been linked to the promotion of cardiovascular health maintenance through its capacity to enhance resistance against oxidative stress, thereby exerting protective effects. The potential involvement of Klotho gene polymorphisms in the regulation of human aging and age-related disorders, including coronary artery disease, chronic renal disease, osteoporosis, and stroke, is under investigation. The objective of our research was to investigate the association between the rs9527025 (Cys370Ser) polymorphism of the Klotho gene and coronary artery calcification, as well as the potential link between the rs9527025 polymorphism and oxidative DNA damage. The study involved a sample of 90 patients who had undergone coronary angiography. The genotyping of Cys370Ser in exon 2 of the Klotho gene was performed using the polymerase chain reaction. The evaluation of oxidative DNA damage was conducted using the alkaline comet test. The findings of the study revealed that there was no statistically significant association between the distribution of alleles in the Klotho SNPs and the occurrence of coronary artery disorders. In the meantime, the total comet score frequency was significantly associated with the rs9527025 polymorphism. The results of our study indicate that Klotho gene variants, particularly the C370S polymorphism (rs9527025), might play a role in influencing oxidative DNA damage in age-related diseases, such as coronary artery disease. In consequence, larger studies are required to confirm the association between Klotho deficiency and the progression of cardiovascular disease in order to elucidate risk factors for coronary artery disease and develop potential therapeutic strategies.
dc.identifier.citationKARSLI S., Yazar S., Karaca M., YURDUN T., "Klotho gene polymorphism as a susceptibility factor for oxidative DNA damage in coronary artery disease", Journal of Research in Pharmacy, cilt.27, sa.5, ss.2079-2086, 2023
dc.identifier.doi10.29228/jrp.486
dc.identifier.endpage2086
dc.identifier.issn2630-6344
dc.identifier.issue5
dc.identifier.startpage2079
dc.identifier.urihttps://avesis.marmara.edu.tr/api/publication/a34f7050-91da-4446-8170-2bb851041b15/file
dc.identifier.urihttps://hdl.handle.net/11424/294247
dc.identifier.volume27
dc.language.isoeng
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectBasic Pharmaceutics Sciences
dc.subjectPharmacology and Therapeutics
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectNatural Sciences
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectLife Sciences (LIFE)
dc.subjectPHARMACOLOGY & TOXICOLOGY
dc.subjectPHARMACOLOGY & PHARMACY
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectCardiovascular disease
dc.subjectcoronary artery disease
dc.subjectgenetic polymorphism
dc.subjectKlotho
dc.subjectoxidative DNA damage
dc.subjectCardiovascular disease
dc.subjectcoronary artery disease
dc.subjectgenetic polymorphism
dc.subjectKlotho
dc.subjectoxidative DNA damage.
dc.titleKlotho gene polymorphism as a susceptibility factor for oxidative DNA damage in coronary artery disease
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
467.56 KB
Format:
Adobe Portable Document Format